Parnell Pharmaceuticals Holdings Ltd (PARNF)

USD 0.11

(120.0%)

Annual Income Statements

(In AUD)
Breakdown 2021 2020 2019 2018 2017 2016
Revenue 34.16 Million 30 Million 28.99 Million 26.54 Million 19.12 Million 19.96 Million
Cost of Revenue 14.9 Million 12.48 Million 11.6 Million 11.02 Million 9.74 Million 8.97 Million
Gross Profit 19.26 Million 17.51 Million 17.38 Million 15.52 Million 9.38 Million 10.98 Million
Operating Expenses 17.91 Million 20.84 Million 16.95 Million 12.1 Million 19.77 Million 28.84 Million
Selling, General and Administrative Expenses 15.08 Million 13.74 Million 16.02 Million 11.66 Million 19.49 Million 27.35 Million
Research and Development Expenses 2.83 Million 1.8 Million 1.38 Million 585.5 Thousand 939.13 Thousand 1.49 Million
Other Expenses - - - -10.41 Thousand -3.48 Million -
Cost and Expenses 32.81 Million 33.32 Million 28.55 Million 23.12 Million 29.51 Million 37.82 Million
Operating Income 1.34 Million 3.77 Million 1.36 Million 2.6 Million -14.26 Million -17.86 Million
Interest Expense - - - 6.18 Million 8.84 Million 3.82 Million
Income Tax Expense 684.00 14.98 Thousand 232.81 Thousand 207.41 Thousand 12.11 Thousand 9054.00
Earnings before Tax -1.41 Million -15.04 Million -6.94 Million 337.03 Thousand -23.11 Million -21.68 Million
Net Income -1.41 Million -15.06 Million -7.18 Million 129.62 Thousand -23.12 Million -21.69 Million
Earnings Per Share Basic -0.05 -0.81 -0.40 - -1.27 -1.37
Earnings Per Share Diluted -0.05 -0.81 -0.40 - -1.27 -1.37
Weighted Average Shares Outstanding 28.96 Million 18.54 Million 18.02 Million - 18.14 Million 15.8 Million
Weighted Average Shares Outstanding (Diluted) 28.96 Million 18.54 Million 18.02 Million - 18.14 Million 15.83 Million
Gross Margin 0.56 0.58 0.60 0.58 0.49 0.55
EBIT Margin 0.18 0.14 0.08 0.20 -0.33 -0.89
Profit Margin -0.04 -0.50 -0.25 0.00 -1.21 -1.09
EBITDA 6 Million 4.22 Million 2.39 Million 5.25 Million -5.91 Million -15.23 Million
Earnings Before Tax Margin 0.04 0.13 0.05 0.10 -0.75 -0.89

Income Statement Charts